Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Multiple Endocrine Neoplasia

• Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
• Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
• Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
• 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
• Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
• Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment
• High Dose Somatostatin Analogues in Neuroendocrine Tumors
• A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
• Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
• Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
• Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
• Treatment of Zollinger-Ellison Syndrome With Prevacid
• Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
• Studies of Elevated Parathyroid Activity